United States· US:61703-319_3aa232be-a3c0-42d6-b959-c152c4136e65

Cytarabine

A cytarabine product containing cytarabine, registered in United States by Hospira, Inc.. The same ATC class is registered in 16 of our 19 countries.

ATC L01BC01

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCytarabineATCL01BC01REGISTER NO.US:61703-319_3aa232be…PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Cytarabine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01BC01 (cytarabine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Cytarabine · ATC L01BC01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CYTARABINE
Manufacturer
Hospira, Inc.
Country
United States (US)
ATC code
L01BC01
ATC class
Cytarabine
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    61703-319-22

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

415 interactions on record for cytarabine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cytarabine · interactions on record

415 records

  • 35 severe
  • 113 moderate
  • 16 minor
  • 251 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CladribineL01BB04severe
  • PexidartinibL01EX15severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cytarabine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cytarabine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Alexan, Cytarabin Accord
  • Belgium · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi
  • Bulgaria · Алексан, Цитарабин Акорд
  • Cyprus · Cytarabine Accord, Cytarabine Pfizer Hellas
  • Czechia · Alexan, Cytarabine Accord
  • Germany · Ara-Cell, Cytarabin Accord
  • Denmark · Cytarabin Fresenius Kabi, Cytarabine Accord
  • Estonia · Cytarabine Accord, Cytarabine Kabi
  • Spain · Citarabina Accord, Citarabina Kabi
  • Finland · Cytarabine Accord, Cytarabine Accord Healthcare
  • France · Aracytine, Cytarabine Accord
  • United Kingdom (Northern Ireland) · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi Oncology
  • Greece · Aracytin, Citabion
  • Croatia · Cytosar
  • Hungary · Alexan, Cytarabine Accord
  • Ireland · Cytarabine, Cytarabine Accord Healthcare Ireland
  • Iceland · Cytarabin Fresenius Kabi, Cytarabine Pfizer
  • Italy · Aracytin, Citarabina Accord
  • Lithuania · Cytarabine Accord, Cytarabine Kabi
  • Luxembourg · Cytosar
  • Latvia · Cytarabine Accord, Cytarabine Kabi
  • Malta · Cytarabine Accord Healthcare, Cytarabine Pfizer Hellas
  • Netherlands · Cytarabine Accord, Cytarabine Fresenius Kabi
  • Norway · Cytarabin Fresenius Kabi, Cytarabine Accord
  • Poland · Alexan, Cytarabina Accord
  • Portugal · Citaloxan, Citarabina Accord
  • Romania · Citarabină Accord, Citarabina Kabi
  • Sweden · Cytarabin Fresenius Kabi, Cytarabin Hikma
  • Slovenia · Citarabin Accord, Cytosar
  • Slovakia · Cytarabine Accord, Cytosar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7e824ba-0f50-4440-8f24-0b8e2aecd7cb
GET /v1/drugs/c7e824ba-0f50-4440-8f24-0b8e2aecd7cb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS",
  "source": "ndc",
  "strength": "100",
  "substance": "CYTARABINE",
  "productndc": "61703-319",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA075383",
  "marketing_category": "ANDA"
}

See everything about cytarabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.